Christy McLaughlin
Psychiatric/Mental Health · Lafayette, INNPI 1578595120
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 505 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,603, 3.6 times the $716 reported in 2021. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 505 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$782
- Vanda Pharmaceuticals Inc.$631
- Axsome Therapeutics, Inc.$576
- Teva Pharmaceuticals USA, Inc.$570
- Supernus Pharmaceuticals, Inc.$547
- plus $4K from 25 others
What the payments were for
- Food & beverage$8,72999%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 89 | $1,412 |
| Otsuka America Pharmaceutical, Inc. | 39 | $782 |
| Vanda Pharmaceuticals Inc. | 25 | $631 |
| Axsome Therapeutics, Inc. | 25 | $576 |
| Teva Pharmaceuticals USA, Inc. | 31 | $570 |
| Supernus Pharmaceuticals, Inc. | 39 | $547 |
| Corium, LLC | 32 | $514 |
| Lundbeck LLC | 40 | $507 |
| Alkermes, Inc. | 23 | $439 |
| Johnson & Johnson | 25 | $397 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $359 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $343 |
| Neos Therapeutics, LP | 16 | $319 |
| Ironshore Pharmaceuticals Inc. | 14 | $272 |
| Neurocrine Biosciences, Inc. | 10 | $201 |
| Noven Therapeutics, LLC | 11 | $192 |
| Tris Pharma Inc | 18 | $174 |
| Bausch Health US, LLC | 8 | $117 |
| Eisai Inc. | 3 | $64 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Biogen | 2 | $45 |
| Indivior Inc. | 2 | $32 |
| Braeburn Inc. | 2 | $31 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Almatica Pharma LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Harmony Biosciences LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$113
How this compares
$8,781 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Lafayette
- Hayley KaelinLafayette$8K
- Leann SharpLafayette$7K
- Bimala DevkotaLafayette$6K
- Diana KingLafayette$5K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.